Genetic Deletion of Sost or Pharmacological Inhibition of Sclerostin Prevent Multiple Myeloma-induced Bone Disease without Affecting Tumor Growth

por Delgado-Calle, Jesus, Anderson, Judith, Cregor, Meloney D., Condon, Keith W., Kuhstoss, Stuart A., Plotkin, Lilian I., Bellido, Teresita, Roodman, G. David
Publicado 2017